导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 22.13% | 801/4982 |
| 近一周 | 0.98% | 911/5417 |
| 近一月 | -5.21% | 3980/5423 |
| 近一季 | -10.31% | 3185/5376 |
| 近半年 | 15.83% | 814/5131 |
| 近一年 | 21.36% | 1012/4741 |
| 近两年 | 74.16% | 1499/4208 |
| 近三年 | 31.84% | 1714/3661 |
| 成立以来 | 530.13% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.07% 2847/5130 |
57.26% 859/5464 |
- - |
- - |
| 2025 | 24.99% 2685/5130 |
-3.37% 4354/4624 |
-2.20% 3951/4802 |
43.13% 620/4970 |
-7.60% 4079/5130 |
| 2024 | -5.10% 3229/4618 |
-4.46% 2494/4340 |
-5.05% 3088/4442 |
11.75% 1697/4550 |
-6.39% 3573/4618 |
| 2023 | -22.76% 2926/4216 |
-2.71% 2944/3759 |
-4.30% 1941/3909 |
-9.78% 2474/4055 |
-8.05% 3351/4209 |
| 2022 | -27.46% 2109/3578 |
-21.91% 2307/2804 |
19.85% 92/3205 |
-11.22% 1347/3430 |
-12.70% 3363/3570 |
| 2021 | 8.70% 655/2717 |
-11.10% 1504/1745 |
20.75% 315/2232 |
3.66% 431/2560 |
-2.32% 1908/2708 |
| 2020 | 85.53% 116/1596 |
6.60% 116/1036 |
34.60% 130/1256 |
7.88% 844/1472 |
19.86% 313/1690 |
| 2019 | 57.33% 157/926 |
30.91% 380/3054 |
-2.22% 2047/3201 |
15.16% 88/939 |
6.74% 674/1014 |
| 2018 | -32.86% 481/668 |
- - |
- - |
- - |
-14.68% 2682/2977 |
| 2017 | 20.46% 163/531 |
- - |
- - |
- - |
- - |
| 2016 | -23.88% 348/455 |
- - |
- - |
- - |
- - |
| 2015 | 88.47% 20/433 |
- - |
- - |
- - |
- - |
| 2014 | 26.12% 193/432 |
- - |
- - |
- - |
- - |
| 2013 | 73.51% 3/398 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 0.9797 | 54.69% |
| 招商创新增长混合A | 1.0526 | 54.25% |
| 招商创新增长混合C | 1.0013 | 53.96% |
| 华泰柏瑞医疗健康A | 2.5834 | 49.29% |
| 招商品质成长混合A | 1.0196 | 49.15% |
| 大摩优悦安和混合A | 0.8851 | 47.23% |
| 大摩优悦安和混合C | 0.8688 | 47.08% |
| 华泰柏瑞医疗健康C | 2.5230 | 44.21% |
| 大摩健康产业混合A | 1.9140 | 32.70% |
| 中信建投医药健康A | 0.7640 | 31.75% |
| 银河主题混合A VS. 长安宏观策略混合A(740001) |